The Headlines – Dr Reddy’s receives two USFDA observations for New York API facility

  • By
  • Posted in News
  • Updated
  • 1 min read
The Headlines – Dr Reddy’s receives two USFDA observations for New York API facility

Dr. Reddy’s Laboratories faced USFDA scrutiny at its New York API facility, receiving a Form 483 with two observations after a GMP inspection concluded on May 16, 2025. The company will address these concerns within the given timeframe.

The Headlines – Business News: Budget 2025, Business News Today, Latest Business News, Stock Markets, Financial News, India Business & World Business News – Read More